Subject: TCHP Prior Authorization Requirement
Effective April 1, 2018, TCHP will be updating the prior authorization listing. This notice will serve as your 90-day advance notification of the change.
Please note there are some key changes for providers.
Removed from the list and will no longer require prior authorization:
Walkers
Vision Care, medically necessary
New to the list:
High cost injectable drugs (>$75K per dose) in an outpatient level of care require prior authorization. Examples include: Kymriah, Spinraza, Exondys
Updates:
Progesterone therapy has been updated to Hydroxyprogesterone caproate injections.
Transplant evaluation has been updated to transplants including solid organ and bone marrow.
The new TCHP prior authorization list will also be posted at: http://www.tchp.us/for-providers/provider-resources
If there are further questions, please contact the Provider Relations Department at 1-800-731-8527